SHINGRIX
As listed in the register: SHINGRIX
50 mcg · suspension
- Prescription status not stated
- Antibiotics, antivirals and antifungals taken into the body
- Active substance
- Varicella-Zoster Virus Glycoprotein E Antigen
- Made by
- Glaxosmithkline Inc
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | Glaxosmithkline Inc |
|---|---|
| Active substance | Varicella-Zoster Virus Glycoprotein E Antigen |
| Used in | Antibiotics, antivirals and antifungals taken into the body |
| Strength | 50 mcg |
| Form | suspension |
| Classification | J07BK · Antibiotics, antivirals and antifungals taken into the body |
| Route | intramuscular |
| Dispensing (as stated by the register) | SCHEDULE D |
| Status | Approved |
| Marketed | No — authorised but not currently marketed, according to the register |
| DIN | 02570270 |
| DPD drug code | 107243 |
Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician
Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.
Other strengths and forms
2 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- suspension2 products
50 mcg2
50 mcg · 2 companies
- Glaxosmithkline Inc · this page
- Glaxosmithkline Inc
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.
See every product with Varicella-Zoster Virus Glycoprotein E Antigen